Owlet Inc. (OWLT) BabySat FDA Submission Seen as a Catalyst - Cowen
Tweet Send to a Friend
Cowen analyst Charles Rhyee reiterated an Outperform rating and $5.00 price target on Owlet Inc. (NYSE: OWLT) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
